Cargando…
Treatment of Benign Prostatic Hyperplasia by Natural Drugs
Benign prostatic hyperplasia (BPH) is one of the most common urinary diseases affecting men, generally after the age of 50. The prevalence of this multifactorial disease increases with age. With aging, the plasma level of testosterone decreases, as well as the testosterone/estrogen ratio, resulting...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659259/ https://www.ncbi.nlm.nih.gov/pubmed/34885733 http://dx.doi.org/10.3390/molecules26237141 |
_version_ | 1784612922054410240 |
---|---|
author | Csikós, Eszter Horváth, Adrienn Ács, Kamilla Papp, Nóra Balázs, Viktória Lilla Dolenc, Marija Sollner Kenda, Maša Kočevar Glavač, Nina Nagy, Milan Protti, Michele Mercolini, Laura Horváth, Györgyi Farkas, Ágnes |
author_facet | Csikós, Eszter Horváth, Adrienn Ács, Kamilla Papp, Nóra Balázs, Viktória Lilla Dolenc, Marija Sollner Kenda, Maša Kočevar Glavač, Nina Nagy, Milan Protti, Michele Mercolini, Laura Horváth, Györgyi Farkas, Ágnes |
author_sort | Csikós, Eszter |
collection | PubMed |
description | Benign prostatic hyperplasia (BPH) is one of the most common urinary diseases affecting men, generally after the age of 50. The prevalence of this multifactorial disease increases with age. With aging, the plasma level of testosterone decreases, as well as the testosterone/estrogen ratio, resulting in increased estrogen activity, which may facilitate the hyperplasia of the prostate cells. Another theory focuses on dihydrotestosterone (DHT) and the activity of the enzyme 5α-reductase, which converts testosterone to DHT. In older men, the activity of this enzyme increases, leading to a decreased testosterone/DHT ratio. DHT may promote prostate cell growth, resulting in hyperplasia. Some medicinal plants and their compounds act by modulating this enzyme, and have the above-mentioned targets. This review focuses on herbal drugs that are most widely used in the treatment of BPH, including pumpkin seed, willow herb, tomato, maritime pine bark, Pygeum africanum bark, rye pollen, saw palmetto fruit, and nettle root, highlighting the latest results of preclinical and clinical studies, as well as safety issues. In addition, the pharmaceutical care and other therapeutic options of BPH, including pharmacotherapy and surgical options, are discussed, summarizing and comparing the advantages and disadvantages of each therapy. |
format | Online Article Text |
id | pubmed-8659259 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86592592021-12-10 Treatment of Benign Prostatic Hyperplasia by Natural Drugs Csikós, Eszter Horváth, Adrienn Ács, Kamilla Papp, Nóra Balázs, Viktória Lilla Dolenc, Marija Sollner Kenda, Maša Kočevar Glavač, Nina Nagy, Milan Protti, Michele Mercolini, Laura Horváth, Györgyi Farkas, Ágnes Molecules Review Benign prostatic hyperplasia (BPH) is one of the most common urinary diseases affecting men, generally after the age of 50. The prevalence of this multifactorial disease increases with age. With aging, the plasma level of testosterone decreases, as well as the testosterone/estrogen ratio, resulting in increased estrogen activity, which may facilitate the hyperplasia of the prostate cells. Another theory focuses on dihydrotestosterone (DHT) and the activity of the enzyme 5α-reductase, which converts testosterone to DHT. In older men, the activity of this enzyme increases, leading to a decreased testosterone/DHT ratio. DHT may promote prostate cell growth, resulting in hyperplasia. Some medicinal plants and their compounds act by modulating this enzyme, and have the above-mentioned targets. This review focuses on herbal drugs that are most widely used in the treatment of BPH, including pumpkin seed, willow herb, tomato, maritime pine bark, Pygeum africanum bark, rye pollen, saw palmetto fruit, and nettle root, highlighting the latest results of preclinical and clinical studies, as well as safety issues. In addition, the pharmaceutical care and other therapeutic options of BPH, including pharmacotherapy and surgical options, are discussed, summarizing and comparing the advantages and disadvantages of each therapy. MDPI 2021-11-25 /pmc/articles/PMC8659259/ /pubmed/34885733 http://dx.doi.org/10.3390/molecules26237141 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Csikós, Eszter Horváth, Adrienn Ács, Kamilla Papp, Nóra Balázs, Viktória Lilla Dolenc, Marija Sollner Kenda, Maša Kočevar Glavač, Nina Nagy, Milan Protti, Michele Mercolini, Laura Horváth, Györgyi Farkas, Ágnes Treatment of Benign Prostatic Hyperplasia by Natural Drugs |
title | Treatment of Benign Prostatic Hyperplasia by Natural Drugs |
title_full | Treatment of Benign Prostatic Hyperplasia by Natural Drugs |
title_fullStr | Treatment of Benign Prostatic Hyperplasia by Natural Drugs |
title_full_unstemmed | Treatment of Benign Prostatic Hyperplasia by Natural Drugs |
title_short | Treatment of Benign Prostatic Hyperplasia by Natural Drugs |
title_sort | treatment of benign prostatic hyperplasia by natural drugs |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659259/ https://www.ncbi.nlm.nih.gov/pubmed/34885733 http://dx.doi.org/10.3390/molecules26237141 |
work_keys_str_mv | AT csikoseszter treatmentofbenignprostatichyperplasiabynaturaldrugs AT horvathadrienn treatmentofbenignprostatichyperplasiabynaturaldrugs AT acskamilla treatmentofbenignprostatichyperplasiabynaturaldrugs AT pappnora treatmentofbenignprostatichyperplasiabynaturaldrugs AT balazsviktorialilla treatmentofbenignprostatichyperplasiabynaturaldrugs AT dolencmarijasollner treatmentofbenignprostatichyperplasiabynaturaldrugs AT kendamasa treatmentofbenignprostatichyperplasiabynaturaldrugs AT kocevarglavacnina treatmentofbenignprostatichyperplasiabynaturaldrugs AT nagymilan treatmentofbenignprostatichyperplasiabynaturaldrugs AT prottimichele treatmentofbenignprostatichyperplasiabynaturaldrugs AT mercolinilaura treatmentofbenignprostatichyperplasiabynaturaldrugs AT horvathgyorgyi treatmentofbenignprostatichyperplasiabynaturaldrugs AT farkasagnes treatmentofbenignprostatichyperplasiabynaturaldrugs AT treatmentofbenignprostatichyperplasiabynaturaldrugs |